Nsaids

What NSAIDs do (core concepts)

  • NSAIDs reduce pain, inflammation, and fever by inhibiting cyclo-oxygenase (COX) enzymes and therefore prostaglandin production.
  • Analgesic effect is opioid-sparing (often reduces opioid requirement and opioid side-effects).
  • COX-1 is involved in gastric protection, platelet function, and renal blood flow, COX-2 is more inducible in inflammation (COX-2 selective drugs tend to cause less gastric irritation but still have renal and cardiovascular risks).
  • They are best used as part of multimodal analgesia (e.g., paracetamol + NSAID ± regional anaesthesia ± opioid as needed).

Common peri-operative NSAIDs in the UK (examples)

  • Ibuprofen: common oral NSAID for ward/discharge, check asthma/renal/GI risk.
  • Diclofenac: oral/PR, useful but higher cardiovascular risk signal than some alternatives, avoid in established ischaemic heart disease/heart failure.
  • Naproxen: longer acting, often considered lower cardiovascular risk than diclofenac (still GI/renal risks).
  • Ketorolac: potent, often used short-term, higher risk of renal impairment and bleeding—use carefully and avoid in high-risk patients.
  • COX-2 selective (e.g., celecoxib/etoricoxib): less platelet effect and less GI ulceration than non-selective NSAIDs, but renal effects still occur, consider cardiovascular risk.

When to consider an NSAID (typical “first time” scenarios)

  • Post-op pain where inflammation contributes (orthopaedics, dental, soft tissue surgery) and there are no major contraindications.
  • When you want opioid-sparing in patients prone to nausea, ileus, sedation, or respiratory depression (but still check renal/GI/bleeding risk).
  • Day-case pathways: a single peri-operative dose can improve comfort and reduce opioid need at home (ensure clear discharge advice).
  • Renal colic: NSAIDs can be very effective (reduce ureteric spasm/inflammation) but avoid if AKI/dehydrated/sepsis.

Pre-op checklist before prescribing/administering

  • Kidneys/volume status: recent creatinine/eGFR if available, avoid if AKI, significant CKD, dehydration, sepsis, or hypotension.
  • GI risk: history of peptic ulcer/upper GI bleed, consider PPI cover if NSAID essential and risk is moderate (follow local policy).
  • Bleeding risk: active bleeding, high-risk surgery for bleeding, thrombocytopenia, coagulopathy, remember non-selective NSAIDs inhibit platelet function (COX-2 selective have minimal platelet effect).
  • Asthma/NSAID sensitivity: ask about previous wheeze, facial swelling, or anaphylaxis after aspirin/ibuprofen/naproxen (avoid if suspected NSAID-exacerbated respiratory disease).
  • Cardiovascular disease: avoid diclofenac in IHD, cerebrovascular disease, peripheral arterial disease, or heart failure, use lowest effective dose for shortest time.
  • Pregnancy: avoid in 3rd trimester (risk of premature ductus arteriosus closure and oligohydramnios), seek senior/obstetric advice if unsure.
  • Drug interactions: ACE inhibitor/ARB + diuretic + NSAID (“triple whammy”) increases AKI risk, anticoagulants/antiplatelets increase bleeding risk, lithium and methotrexate toxicity can be increased.

Dosing principles (safe practice)

  • Use the lowest effective dose for the shortest time, reassess daily in inpatients.
  • Avoid stacking multiple NSAIDs (e.g., ibuprofen plus diclofenac) — no added benefit, increased harm.
  • If giving peri-operatively, document timing and agent clearly to avoid duplicate dosing on the ward.
  • Consider gastroprotection (e.g., PPI) for higher GI-risk patients if NSAID is needed and not contraindicated (follow local guidance).

Adverse effects to recognise early

  • Renal: reduced renal perfusion → AKI, fluid retention, higher risk with dehydration, sepsis, CKD, ACEi/ARB, diuretics, elderly.
  • GI: dyspepsia, gastritis, ulceration, GI bleeding (may be occult).
  • Bleeding: platelet inhibition (non-selective NSAIDs) can increase surgical bleeding, risk depends on procedure and patient factors.
  • Respiratory/allergy: bronchospasm in susceptible asthma, urticaria/angioedema, anaphylaxis (rare).
  • Cardiovascular: fluid retention, hypertension, worsening heart failure, thrombotic risk varies by agent and dose.

Practical peri-operative tips

  • If hypotensive, septic, bleeding, or clearly volume-depleted: avoid NSAIDs and choose alternatives (paracetamol, regional techniques, opioids carefully).
  • After major surgery with high AKI risk (e.g., major abdominal, vascular): be cautious—discuss with senior and consider delaying until stable and euvolaemic.
  • If neuraxial/regional anaesthesia: NSAIDs alone are not usually a contraindication, but consider overall bleeding risk and other anticoagulants, follow local/regional guidelines.
  • On discharge: advise to avoid additional over-the-counter NSAIDs and to stop and seek help if black stools, vomiting blood, severe abdominal pain, wheeze, facial swelling, or reduced urine output.

Test yourself…

What is the main mechanism of NSAIDs?

– Inhibit COX enzymes → reduce prostaglandins – Leads to analgesic, anti-inflammatory, and antipyretic effects

Why can NSAIDs cause AKI?

– Prostaglandins help maintain renal blood flow (especially when kidneys are “stressed”) – NSAIDs remove this support → reduced renal perfusion, particularly in dehydration, sepsis, CKD, ACEi/ARB + diuretic use

Which patients should I avoid NSAIDs in (common peri-op list)?

– AKI or significant CKD – Hypovolaemia/dehydration, sepsis, ongoing hypotension – Active GI ulcer/bleed or very high GI bleed risk – Known NSAID/aspirin allergy or NSAID-triggered asthma – Severe heart failure, avoid diclofenac in established atherosclerotic disease

Do NSAIDs increase bleeding?

– Non-selective NSAIDs inhibit platelet function (reversible) – Clinically relevant bleeding risk depends on surgery type and patient factors – COX-2 selective agents have minimal platelet effect but still carry renal/CV risks

Can I give an NSAID with LMWH or DOACs?

– Caution: combined therapy increases bleeding risk – If analgesic benefit is important, discuss with senior and consider COX-2 selective options and gastroprotection (as appropriate) – Avoid if bleeding risk is high

What is the ‘triple whammy’?

– ACE inhibitor/ARB + diuretic + NSAID – Markedly increases AKI risk, especially with dehydration or intercurrent illness

When are NSAIDs particularly helpful?

– Inflammatory pain (e.g., orthopaedics, dental, soft tissue) – Opioid-sparing in patients prone to nausea/sedation – Renal colic (if kidneys and volume status are OK)

If a patient has asthma, can they have ibuprofen?

– Many asthmatics tolerate NSAIDs – Avoid if history suggests NSAID-exacerbated respiratory disease (wheeze/nasal symptoms after aspirin/NSAID) – If unsure or severe asthma: discuss with senior and consider alternatives

What should I monitor after starting an NSAID in hospital?

– Urine output and fluid balance – Creatinine/eGFR if ongoing use or high-risk patient – Signs of GI bleeding (melaena, haematemesis, unexplained anaemia) – Blood pressure/heart failure symptoms in susceptible patients

0 comments